Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
fda
gene therapy
4
×
life sciences
national
national blog main
national top stories
4
×
new york top stories
san francisco top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
sarepta therapeutics
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biogen
cystic fibrosis
deals
drug prices
duchenne muscular dystrophy
genentech
novartis
roche
spark therapeutics
What
fda
4
×
bio
drugs
roundup
drug
news
patients
therapy
ahead
approved
aren’t
asco
atrophy
august
biotech
branded
busy
choices
commissioner
consumers
costly
counterweight
daily
days
decisions
developers
devices
elevatebio
evrysdi
friday
gene
generic
graft
green
help
home
imminent
intended
legacy
lights
Language
unset
Current search:
fda
×
" national top stories "
×
" gene therapy "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More